Elevance Health, Inc.
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Parent Company Cash and Investments by Quarter
Parent Company Cash and Investments (Quarterly 8-K Disclosure) ($M)
Elevance Health Parent Company Cash and Investments: $2,400M in Q3 2026, down 7.7% from a year earlier.
Where the Q3 2026 figure comes from
“As of September 30, 2026, cash and investments at the parent company totaled approximately $2.4 billion.”
Source: 8-K ER (FY2026Q3, 2026-10-21) ↗
Quarterly liquidity held directly at the parent holding company (reported in every Form 8-K earnings release).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Parent Company Cash and Investments (Quarterly 8-K Disclosure) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 2,400 | -7.7% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 2,100 | -4.5% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2026 | Mar 31, 2026 | 2,200 | +57.1% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2025 | Dec 31, 2025 | 2,600 | +8.3% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2025 | Sep 30, 2025 | 2,600 | 0.0% | 8-K ER (FY2025Q3, 2025-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 2,200 | -8.3% | 8-K ER (FY2025Q2, 2025-07-17) ↗ |
| Q1 2025 | Mar 31, 2025 | 1,400 | +40.0% | 8-K ER (FY2025Q1, 2025-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 2,400 | +50.0% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| Q3 2024 | Sep 30, 2024 | 2,600 | +52.9% | 8-K ER (FY2024Q3, 2024-10-17) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,400 | +140.0% | 8-K ER (FY2024Q2, 2024-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,000 | -9.1% | 8-K ER (FY2024Q1, 2024-04-18) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,600 | +33.3% | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
| Q3 2023 | Sep 30, 2023 | 1,700 | +70.0% | 8-K ER (FY2023Q3, 2023-10-18) ↗ |
| Q2 2023 | Jun 30, 2023 | 1,000 | +5.5% | 8-K ER (FY2023Q2, 2023-07-19) ↗ |
| Q1 2023 | Mar 31, 2023 | 1,100 | – | 8-K ER (FY2023Q1, 2023-04-19) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,200 | 0.0% | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| Q3 2022 | Sep 30, 2022 | 1,000 | -28.6% | 8-K ER (FY2022Q3, 2022-10-19) ↗ |
| Q2 2022 | Jun 30, 2022 | 948 | -3.3% | 8-K ER (FY2022Q2, 2022-07-20) ↗ |
| Q4 2021 | Dec 31, 2021 | 1,200 | -29.4% | 8-K ER (FY2021Q4, 2022-01-26) ↗ |
| Q3 2021 | Sep 30, 2021 | 1,400 | -46.2% | 8-K ER (FY2021Q3, 2021-10-20) ↗ |
| Q2 2021 | Jun 30, 2021 | 980 | -76.1% | 8-K ER (FY2021Q2, 2021-07-21) ↗ |
| Q1 2021 | Mar 31, 2021 | 4,600 | +170.6% | 8-K ER (FY2021Q1, 2021-04-21) ↗ |
| Q4 2020 | Dec 31, 2020 | 1,700 | -37.0% | 8-K ER (FY2020Q4, 2021-01-27) ↗ |
| Q3 2020 | Sep 30, 2020 | 2,600 | -13.3% | 8-K ER (FY2020Q3, 2020-10-28) ↗ |
| Q2 2020 | Jun 30, 2020 | 4,100 | +192.9% | 8-K ER (FY2020Q2, 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 1,700 | +54.5% | 8-K ER (FY2020Q1, 2020-04-29) ↗ |
| Q4 2019 | Dec 31, 2019 | 2,700 | +42.1% | 8-K ER (FY2019Q4, 2020-01-29) ↗ |
| Q3 2019 | Sep 30, 2019 | 3,000 | +25.0% | 8-K ER (FY2019Q3, 2019-10-23) ↗ |
| Q2 2019 | Jun 30, 2019 | 1,400 | -36.4% | 8-K ER (FY2019Q2, 2019-07-24) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,100 | 0.0% | 8-K ER (FY2019Q1, 2019-04-24) ↗ |
| Q4 2018 | Dec 31, 2018 | 1,900 | -32.1% | 8-K ER (FY2018Q4, 2019-01-30) ↗ |
| Q3 2018 | Sep 30, 2018 | 2,400 | – | 8-K ER (FY2018Q3, 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 2,200 | – | 8-K ER (FY2018Q2, 2018-07-25) ↗ |
| Q1 2018 | Mar 31, 2018 | 1,100 | – | 8-K ER (FY2018Q1, 2018-04-25) ↗ |
| Q4 2017 | Dec 31, 2017 | 2,800 | – | 8-K ER (FY2017Q4, 2018-01-31) ↗ |
Breakdown
What makes up parent Company Cash and Investments
Cite this data
StockData. (2026). Elevance Health Parent Company Cash and Investments ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/parent-cash-and-investments-8k
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.